JP2011507847A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011507847A5 JP2011507847A5 JP2010539482A JP2010539482A JP2011507847A5 JP 2011507847 A5 JP2011507847 A5 JP 2011507847A5 JP 2010539482 A JP2010539482 A JP 2010539482A JP 2010539482 A JP2010539482 A JP 2010539482A JP 2011507847 A5 JP2011507847 A5 JP 2011507847A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- alkyl
- dba
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 35
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims 22
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 239000002253 acid Substances 0.000 claims 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- 229910052723 transition metal Inorganic materials 0.000 claims 6
- 150000003624 transition metals Chemical class 0.000 claims 6
- 125000001309 chloro group Chemical group Cl* 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 101710043771 PDCL Proteins 0.000 claims 4
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 4
- 239000003054 catalyst Substances 0.000 claims 4
- 125000001153 fluoro group Chemical group F* 0.000 claims 4
- 125000004994 halo alkoxy alkyl group Chemical group 0.000 claims 4
- 125000001188 haloalkyl group Chemical group 0.000 claims 4
- 229910052763 palladium Inorganic materials 0.000 claims 4
- 238000000634 powder X-ray diffraction Methods 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 3
- YCIMNLLNPGFGHC-UHFFFAOYSA-N Catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 230000027455 binding Effects 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- FEJUGLKDZJDVFY-UHFFFAOYSA-N 9-borabicyclo[3.3.1]nonane Substances C1CCC2CCCC1B2 FEJUGLKDZJDVFY-UHFFFAOYSA-N 0.000 claims 1
- 208000006673 Asthma Diseases 0.000 claims 1
- AXXLAOYVJJFFKW-UHFFFAOYSA-N B1CCCCCCCC1C1CCCCCCCC1 Chemical compound B1CCCCCCCC1C1CCCCCCCC1 AXXLAOYVJJFFKW-UHFFFAOYSA-N 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- IVDFJHOHABJVEH-UHFFFAOYSA-N Pinacol Chemical compound CC(C)(O)C(C)(C)O IVDFJHOHABJVEH-UHFFFAOYSA-N 0.000 claims 1
- 206010039083 Rhinitis Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 230000000240 adjuvant Effects 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- -1 chloro, bromo, iodo Chemical group 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 201000004624 dermatitis Diseases 0.000 claims 1
- 231100000406 dermatitis Toxicity 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- XGJJEPKJCFKYKE-UHFFFAOYSA-N ditert-butyl-[2-tert-butyl-6-[2,4,6-tri(propan-2-yl)phenyl]phenyl]phosphane Chemical group CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC(C(C)(C)C)=C1P(C(C)(C)C)C(C)(C)C XGJJEPKJCFKYKE-UHFFFAOYSA-N 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims 1
- 229910000043 hydrogen iodide Inorganic materials 0.000 claims 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 claims 1
- 229910001511 metal iodide Inorganic materials 0.000 claims 1
- 239000003638 reducing agent Substances 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- 0 CC(C)(C)*C(c(cc1*C(c2ccc(C)cc2I)=O)ccc1Oc1c(C)cc(CC(O)=O)c(N)c1)=O Chemical compound CC(C)(C)*C(c(cc1*C(c2ccc(C)cc2I)=O)ccc1Oc1c(C)cc(CC(O)=O)c(N)c1)=O 0.000 description 4
Claims (34)
- Xはクロロである、請求項1に記載の化合物。
- R1はアルキルである、請求項1に記載の化合物。
- R1はt−ブチルである、請求項3に記載の化合物。
- R2はシクロアルキルである、請求項1に記載の化合物。
- R2はシクロプロピルである、請求項5に記載の化合物。
- DSCを用いて分析すると熱転移が1回あるフォームII無水遊離酸であり、前記1回の熱転移は約203℃での吸熱転移である、請求項8に記載の化合物。
- 前記1回の熱転移は約203.22℃での吸熱転移である、請求項9に記載の化合物。
- 2−θについて約19.2における特徴ピークを含む粉末X線回折パターンを有するフォームII無水遊離酸である、請求項8に記載の化合物。
- 2−θについて約9.5における特徴ピークをさらに含む粉末X線回折パターンを有する、請求項11に記載の化合物。
- 2−θについて約22.0、20.2、17.2、および16.6において特徴ピークをさらに含む粉末X線回折パターンを有する、請求項12に記載の化合物。
- 2−θについて図8に示す通りの特徴ピークを含む粉末X線回折パターンを有する、請求項13に記載の化合物。
- 請求項1に記載の化合物の治療上有効量と、医薬的に許容されるビヒクルアジュバントまたは希釈剤と、を含む薬学的組成物。
- 喘息を治療するための、請求項15に記載の薬学的組成物。
- COPDを治療するための、請求項15に記載の薬学的組成物。
- 鼻炎を治療するための、請求項15に記載の薬学的組成物。
- 皮膚炎を治療するための、請求項15に記載の薬学的組成物。
- 遷移金属はパラジウムを含む、請求項20に記載の方法。
- パラジウム源は、(η3−C3H5)2Pd2Cl2、Pd2(dba)3、Pd/C、PdCl2、Pd(OAc)2、(CH3CN)2PdCl2、Pd[P(C6H5)3]4、Pd2(dba)3、およびPd(dba)2から選択される、請求項21に記載の方法。
- 遷移金属触媒は、配位子t−ブチル−2−ジ−tertブチルホスフィノ−2’,4’,6’−トリイソプロピル−1,1’−ビフェニルを含む、請求項22に記載の方法。
- a)遷移金属触媒;および
b)塩基;
の存在下、式Hの化合物:
[Yは、−(OR)2、−F3 −、またはR’2であり;
Rは独立して、H、アルキル、アリール、またはアリールアルキルであるか;
或いは2つのR基は一緒になってピナコールまたはカテコールを形成し得;
R’はアルキルであるか、または2つのR’が一緒になって9−ボラビシクロノナンを形成し得(9−BBN);
Mは、ZnまたはMgであり;および
X1は、Cl、Br、またはIである]から選択される化合物と接触させて、式Jの化合物:
を含む方法により式Bの化合物を調製する、請求項20に記載の方法。 - 遷移金属はパラジウムを含む、請求項26に記載の方法。
- パラジウム源は、(η3−C3H5)2Pd2Cl2、Pd2(dba)3、Pd/C、PdCl2、Pd(OAc)2、(CH3CN)2PdCl2、Pd[P(C6H5)3]4、Pd2(dba)3、およびPd(dba)2から選択される、請求項27に記載の方法。
- 遷移金属触媒は、トリアリールホスフィンおよびトリアルキルホスフィンから選択される配位子を含む、請求項28に記載の方法。
- 式Jの化合物を続けて酸で処理して式Bの化合物を形成させる、請求項26に記載の方法。
- 請求項20の方法により作製される、請求項33に記載の化合物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US843307P | 2007-12-19 | 2007-12-19 | |
US61/008,433 | 2007-12-19 | ||
PCT/US2008/013833 WO2009085177A1 (en) | 2007-12-19 | 2008-12-18 | Phenyl acetic acid derivatives as inflammation modulators |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2011507847A JP2011507847A (ja) | 2011-03-10 |
JP2011507847A5 true JP2011507847A5 (ja) | 2011-12-22 |
JP5437267B2 JP5437267B2 (ja) | 2014-03-12 |
Family
ID=40564868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010539482A Expired - Fee Related JP5437267B2 (ja) | 2007-12-19 | 2008-12-18 | 炎症モジュレーターとしてのフェニル酢酸誘導体 |
Country Status (20)
Country | Link |
---|---|
US (1) | US8183293B2 (ja) |
EP (1) | EP2231595B1 (ja) |
JP (1) | JP5437267B2 (ja) |
KR (1) | KR20100102668A (ja) |
CN (1) | CN101903338A (ja) |
AR (1) | AR071279A1 (ja) |
AU (1) | AU2008343924B2 (ja) |
BR (1) | BRPI0821197A2 (ja) |
CA (1) | CA2707789A1 (ja) |
CL (1) | CL2008003832A1 (ja) |
CO (1) | CO6321234A2 (ja) |
CR (1) | CR11572A (ja) |
EA (1) | EA201001029A1 (ja) |
ES (1) | ES2471919T3 (ja) |
IL (1) | IL206069A0 (ja) |
MA (1) | MA32013B1 (ja) |
PE (1) | PE20091526A1 (ja) |
TN (1) | TN2010000223A1 (ja) |
TW (1) | TW200940051A (ja) |
WO (1) | WO2009085177A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2457900A1 (en) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | New pyrazole derivatives having CRTh2 antagonistic behaviour |
WO2013088109A1 (en) | 2011-12-16 | 2013-06-20 | Oxagen Limited | Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis |
US9974759B2 (en) * | 2013-05-31 | 2018-05-22 | Indiana University Research And Technology Corporation | Beta 2 adrenoceptor antagonists for treating orthostatic hypotension |
WO2016128565A1 (en) * | 2015-02-13 | 2016-08-18 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus |
MY195948A (en) | 2016-03-22 | 2023-02-27 | Merck Sharp & Dohme | Allosteric Modulators of Nicotinic Acetylcholine Receptors |
ES2733477T3 (es) * | 2017-07-04 | 2019-11-29 | Fis Fabbrica Italiana Sintetici Spa | Procedimiento eficaz para la preparación de sitagliptina a través de una preparación muy eficaz del intermedio ácido 2,4,5-trifluorofenilacético |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8704158D0 (en) | 1987-02-23 | 1987-04-01 | Wellcome Found | Substituted hydantoin compounds |
US5849780A (en) | 1992-01-30 | 1998-12-15 | Sanofi | 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present |
HUT73813A (en) | 1993-06-30 | 1996-09-30 | Wellcome Found | Anti-athero-sclerotic diaryl compounds, process to prepare them and pharmaceutical compositions contg. them |
US5545669A (en) | 1994-06-02 | 1996-08-13 | Adams; Jerry L. | Anti-inflammatory compounds |
ATE223899T1 (de) * | 1994-12-20 | 2002-09-15 | Hoffmann La Roche | Aryl-und hetaryl-sulfonamid derivate, deren herstellung und deren verwendung als endothelin- antagonisten |
US6008234A (en) * | 1996-09-12 | 1999-12-28 | Berlex Laboratories, Inc. | Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants |
CN1234798A (zh) | 1996-09-12 | 1999-11-10 | 舍林股份公司 | 环状氨基酸和环状羟基羧酸衍生物取代的苄脒衍生物和它们用作抗凝剂的用途 |
TW523506B (en) | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
JPH11202458A (ja) | 1998-01-16 | 1999-07-30 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料 |
US5929250A (en) | 1997-01-23 | 1999-07-27 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
EP1076641A1 (en) | 1998-04-29 | 2001-02-21 | Vertex Pharmaceuticals Incorporated | Inhibitors of impdh enzyme |
AR023659A1 (es) | 1998-09-18 | 2002-09-04 | Vertex Pharma | Un compuesto inhibidor de p38, una composicion farmaceutica que lo comprende y el uso de dicha composicion en el tratamiento y prevencion de estados patologicos |
US6248739B1 (en) | 1999-01-08 | 2001-06-19 | Pharmacia & Upjohn Company | Quinolinecarboxamides as antiviral agents |
AU772282B2 (en) | 1999-03-01 | 2004-04-22 | Pfizer Products Inc. | Oxamic acids and derivatives as thyroid receptor ligands |
AU2825000A (en) | 1999-03-10 | 2000-09-28 | Shionogi & Co., Ltd. | Medicinal compositions with (2.2.1) and (3.1.1) bicycloskeleton antagonistic to both of pgd2/txa2 receptors |
DE1211513T1 (de) | 1999-08-23 | 2002-11-14 | Bml Inc | Verfahren zum identifizieren von substanzen, die an prostaglandin d rezeptoren binden können |
US6531291B1 (en) * | 1999-11-10 | 2003-03-11 | The Trustees Of Columbia University In The City Of New York | Antimicrobial activity of gemfibrozil and related compounds and derivatives and metabolites thereof |
EP1255750A1 (en) | 2000-02-01 | 2002-11-13 | Millenium Pharmaceuticals, Inc. | INDOLE AND BENZIMIDAZOLE INHIBITORS OF FACTOR Xa |
US20010047027A1 (en) | 2000-04-12 | 2001-11-29 | Marc Labelle | Prostaglandin D2 receptor antagonists |
US7084136B2 (en) | 2000-06-02 | 2006-08-01 | Shionogi & Co., Ltd. | Drug composition antagonistic to both PGD2/TXA2 receptors |
US6878522B2 (en) | 2000-07-07 | 2005-04-12 | Baiyong Li | Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
WO2002045718A1 (en) | 2000-12-08 | 2002-06-13 | Institut Pasteur De Lille | Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells |
WO2002051805A1 (de) | 2000-12-27 | 2002-07-04 | Bayer Aktiengesellschaft | Indol-derivate |
ES2272712T3 (es) | 2001-05-23 | 2007-05-01 | Merck Frosst Canada Ltd. | Derivados de dihidropirrolo-1,2-aiindol y tetrahidropirido -1,2-aiindol como antagonistas de receptores de prostaglandina d2. |
JP4529119B2 (ja) | 2001-08-09 | 2010-08-25 | 小野薬品工業株式会社 | カルボン酸誘導体化合物およびその化合物を有効成分として含有する薬剤 |
SE0200411D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
SE0200356D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
BR0308518A (pt) | 2002-03-19 | 2005-02-22 | Ono Pharmaceutical Co | Compostos ácidos carboxìlicos e drogas contendo os compostos como o ingrediente ativo |
JP4484108B2 (ja) | 2002-05-16 | 2010-06-16 | 塩野義製薬株式会社 | Pgd2受容体拮抗作用を有する化合物 |
AU2003231513A1 (en) | 2002-05-16 | 2003-12-02 | Shionogi And Co., Ltd. | Pgd2 receptor antagonist |
GB2388540A (en) | 2002-05-17 | 2003-11-19 | Bayer Ag | New use of Ramatroban |
SE0201635D0 (sv) | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
TW200307542A (en) | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
GB0224557D0 (en) | 2002-10-22 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
BR0317591A (pt) * | 2002-12-20 | 2005-11-22 | Amgen Inc | Composto, sal ou pró-medicamento farmaceuticamente aceitáveis, composição farmacêutica, e, métodos para tratar uma doença ou condição, para modular a função de crth2 e/ou um ou mais outros receptores de pgd2 em uma célula e para modular crth2 e/ou um ou mais outros receptores de pgd2 |
ES2299906T3 (es) | 2003-11-25 | 2008-06-01 | Eli Lilly And Company | Moduladores de receptores activados por proliferadores de peroxisomas. |
WO2007039736A1 (en) * | 2005-10-06 | 2007-04-12 | Astrazeneca Ab | Novel compounds |
KR20090089868A (ko) * | 2006-12-15 | 2009-08-24 | 글락소 그룹 리미티드 | Ep4 수용체 작동제로서 벤즈아미드 유도체 |
US7960567B2 (en) * | 2007-05-02 | 2011-06-14 | Amgen Inc. | Compounds and methods useful for treating asthma and allergic inflammation |
JP2013500978A (ja) | 2009-07-31 | 2013-01-10 | パンミラ ファーマシューティカルズ,エルエルシー. | Dp2受容体アンタゴニストの眼の医薬組成物 |
CN102596193A (zh) | 2009-07-31 | 2012-07-18 | 潘米拉制药公司 | Dp2受体拮抗的皮肤调配物 |
-
2008
- 2008-12-18 EA EA201001029A patent/EA201001029A1/ru unknown
- 2008-12-18 KR KR1020107015813A patent/KR20100102668A/ko not_active Application Discontinuation
- 2008-12-18 BR BRPI0821197-3A patent/BRPI0821197A2/pt not_active IP Right Cessation
- 2008-12-18 CA CA2707789A patent/CA2707789A1/en not_active Abandoned
- 2008-12-18 WO PCT/US2008/013833 patent/WO2009085177A1/en active Application Filing
- 2008-12-18 JP JP2010539482A patent/JP5437267B2/ja not_active Expired - Fee Related
- 2008-12-18 ES ES08867490.8T patent/ES2471919T3/es active Active
- 2008-12-18 EP EP08867490.8A patent/EP2231595B1/en active Active
- 2008-12-18 US US12/317,066 patent/US8183293B2/en active Active
- 2008-12-18 CN CN2008801215268A patent/CN101903338A/zh active Pending
- 2008-12-18 AU AU2008343924A patent/AU2008343924B2/en not_active Ceased
- 2008-12-19 AR ARP080105608A patent/AR071279A1/es not_active Application Discontinuation
- 2008-12-19 TW TW097149926A patent/TW200940051A/zh unknown
- 2008-12-19 CL CL2008003832A patent/CL2008003832A1/es unknown
- 2008-12-19 PE PE2008002152A patent/PE20091526A1/es not_active Application Discontinuation
-
2010
- 2010-05-20 TN TN2010000223A patent/TN2010000223A1/fr unknown
- 2010-05-30 IL IL206069A patent/IL206069A0/en unknown
- 2010-07-14 MA MA33012A patent/MA32013B1/fr unknown
- 2010-07-19 CO CO10087808A patent/CO6321234A2/es not_active Application Discontinuation
- 2010-07-19 CR CR11572A patent/CR11572A/es not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2011507847A5 (ja) | ||
JP2019516692A5 (ja) | ||
JP2018529687A5 (ja) | ||
JP2010174033A5 (ja) | ||
JP2010500343A5 (ja) | ||
JP2010500293A5 (ja) | ||
JP2013530150A5 (ja) | ||
JP2007260659A5 (ja) | 液相反応用のポリシラン担持遷移金属触媒 | |
JP2008505171A5 (ja) | ||
JP2008513358A5 (ja) | ||
JP2010513494A5 (ja) | ||
JP2009535350A (ja) | シナカルセット塩基の調製法 | |
TW201002682A (en) | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine | |
JP2006519818A5 (ja) | ||
JP2008520662A5 (ja) | ||
JP2015524406A5 (ja) | ||
JP2014511859A (ja) | Hivインテグラーゼ阻害剤の調製のためのプロセス | |
JP2016509042A (ja) | ボルチオキセチンの製造方法 | |
WO2003014087A1 (fr) | Procede de preparation de 5-methyl-1-phenyl-2(1h)-pyridinone | |
JP2008088159A (ja) | O−デスメチルベンラファキシンの合成方法 | |
JP2022116233A5 (ja) | ||
JP2013520495A5 (ja) | ||
JP2010501617A5 (ja) | ||
JP2013541589A5 (ja) | ||
JP2013234194A5 (ja) |